Literature DB >> 11391607

Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed.

S Krishnamurthy1, D G Bedi, N P Caraway.   

Abstract

BACKGROUND: Ultrasound (US) has been shown to be a sensitive technique for monitoring patients for recurrent thyroid carcinoma in the thyroid bed after total thyroidectomy. However, the role of US-guided fine-needle aspiration biopsy (FNAB) in the confirmation of sonographically indeterminate or suspicious masses has not been adequately addressed. The purposes of this study were to determine the sensitivity and specificity of US-guided FNAB of the thyroid bed for diagnosing recurrent carcinoma after total thyroidectomy and to highlight potential diagnostic pitfalls.
METHODS: Twenty-one patients with a history of total thyroidectomy and histologically confirmed thyroid carcinoma who had undergone US-guided FNAB of hypoechoic lesions in the thyroid bed were included in this retrospective study. Fifteen of the 21 had papillary carcinoma (PC), 5 had medullary carcinoma (MC), and 1 had Hürthle cell carcinoma (HTC). The cytologic features of the aspirates were compared with histopathologic findings of pre- and post-FNA surgery. Immunohistochemical staining for thyroglobulin, calcitonin, and parathyroid hormone was performed in four cases.
RESULTS: The cytologic diagnosis from the US-guided FNABs was conclusive in 20 of 21 cases. Fifteen cases were diagnosed as recurrent tumor (12 PC, 2 MC, and 1 HTC), and 13 of the 15 were confirmed subsequently by histology. Five cases were diagnosed as benign (two residual benign thyroid tissue, one parathyroid gland [PG] tissue, and two reparative changes) and hence were not resected. There was one false-positive diagnosis in which PG was misdiagnosed as PC. Immunohistochemical studies helped to confirm the diagnosis of PG tissue in two cases and of MC in two cases. The sensitivity of US-guided FNA for diagnosing recurrent carcinoma in the thyroid bed after total thyroidectomy was 100% and the specificity was 85.7%.
CONCLUSIONS: US-guided FNAB was found to be a sensitive and specific test for diagnosing sonographically indeterminate lesions in the thyroid bed. One potential diagnostic pitfall was the misdiagnosis of normal residual thyroid or PG tissue as recurrent tumor. Careful attention to cytologic details and the use of selected immunohistochemical staining may help to prevent these misdiagnoses. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11391607     DOI: 10.1002/cncr.9029

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Evaluation of Thyroid Bed Nodules on Ultrasonography after Total Thyroidectomy: Risk for Loco-Regional Recurrence of Thyroid Cancer.

Authors:  Chitra Choudhary; Leonard Wartofsky; Eshetu Tefera; Kenneth D Burman
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma.

Authors:  Fabio Pomerri; Anna Rita Cervino; Faise Al Bunni; Laura Evangelista; Pier Carlo Muzzio
Journal:  Radiol Med       Date:  2013-11-26       Impact factor: 3.469

3.  An unexpected bilateral mass after total thyroidectomy.

Authors:  Rosa Cannistraci; Edgardo Bonacina; Alessandro Garbellini; Emanuele Muraca; Stefano Ciardullo; Giuseppina Manzoni; Franco Mattavelli; Gianluca Perseghin; Francesca Zerbini
Journal:  Endocrine       Date:  2021-02-25       Impact factor: 3.633

4.  2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.

Authors:  L Leenhardt; M F Erdogan; L Hegedus; S J Mandel; R Paschke; T Rago; G Russ
Journal:  Eur Thyroid J       Date:  2013-09-05

Review 5.  Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature.

Authors:  Francesco Bertagna; Giorgio Biasiotto; Emanuela Orlando; Giovanni Bosio; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

6.  ¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.

Authors:  Sandra J Rosenbaum-Krumme; Rainer Görges; Andreas Bockisch; Ina Binse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-21       Impact factor: 9.236

7.  Ultrasound guided fine needle aspiration biopsy of parathyroid gland and lesions.

Authors:  Haytham Dimashkieh; Savitri Krishnamurthy
Journal:  Cytojournal       Date:  2006-03-28       Impact factor: 2.091

8.  Fine-needle aspiration of the thyroid: an overview.

Authors:  Gia-Khanh Nguyen; Mark W Lee; Jody Ginsberg; Tina Wragg; Darcy Bilodeau
Journal:  Cytojournal       Date:  2005-06-29       Impact factor: 2.091

9.  Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.

Authors:  Jandee Lee; Kuk Young Nah; Ra Mi Kim; Yeon-Ju Oh; Young-Sil An; Joon-Kee Yoon; Gwang Il An; Tae Hyun Choi; Gi Jeong Cheon; Euy-Young Soh; Woong Youn Chung
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

10.  Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules <10 mm in the maximum diameter: does size matter?

Authors:  Yi-Jun Lyu; Fang Shen; Yun Yan; Ming-Zhu Situ; Wei-Zhu Wu; Guo-Qiang Jiang; Ya-Ya Chen
Journal:  Cancer Manag Res       Date:  2019-02-07       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.